Evidence-Based Medical News

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Text Size

Log in / Sign up

Acne vulgaris

Subtypes of Acne vulgaris

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Acne vulgaris

171 trials tracked for Acne vulgaris: 113 in phase 3 or 4 and 15 with published results. The most-cited published study has 142 citations.

171Trials tracked

113Phase 3 & 4

0Recruiting

15With published results

Phase distribution

Phase 4 50 Phase 3 63 Phase 2 39 Phase 1 4 Other / NA 15

Phase 3 A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) Completed · 142 cited
Phase 3 A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) Completed · 141 cited
Phase 4 Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars Completed · 69 cited
Phase 3 Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris Completed · 69 cited
Phase 3 Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris Completed · 60 cited
Phase 3 A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris Completed · 29 cited

Show 44 more trials

Phase 4 Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation Completed · 28 cited
Phase 4 DUAC® Early Onset Efficacy Study in Japanese Subjects Completed · 20 cited
Phase 3 Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris Completed · 17 cited
Phase 3 A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris Completed · 17 cited
Phase 3 Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne Completed · 17 cited
Phase 4 Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris Completed · 10 cited
Phase 3 Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris Completed · 7 cited
Phase 3 Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris Completed · 7 cited
Phase 4 A Treatment for Severe Inflammatory Acne Subjects Completed · 6 cited
Phase 4 A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris Completed
Phase 4 8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat Acne Completed
Phase 4 Measuring Adherence in Subjects With Acne Vulgaris in a Clinic Population Subtitle: Topical Benzoyl Peroxide for Acne Completed
Phase 4 Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris Completed
Phase 4 U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY™ II to PROACTIV™ Completed
Phase 4 Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris Completed
Phase 4 U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne Completed
Phase 4 Effect of Samples on Acne Treatment With Epiduo® Gel Completed
Phase 4 The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color Completed
Phase 4 Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris Completed
Phase 4 Effects of Oral Zinc Gluconate Among Acne Vulgaris Patients Completed
Phase 4 A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV) Completed
Phase 4 Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color Completed
Phase 4 Subantimicrobial Doxycycline in Acne Completed
Phase 4 AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation Completed
Phase 4 A Study to Evaluate the Impact of Clascoterone 1% Cream on Skin Barrier Properties in Acne Prone Patients Completed
Phase 4 A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With Acne Completed
Phase 4 A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne Completed
Phase 4 A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne Completed
Phase 4 Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face Completed
Phase 4 A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris Completed
Phase 4 Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne Completed
Phase 4 Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH) Completed
Phase 4 Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1% Completed
Phase 4 Anti Propionibacterium(P.) Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel Completed
Phase 4 Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris Completed
Phase 4 Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications Completed
Phase 4 Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris Completed
Phase 4 Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications Completed
Phase 4 Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris Completed
Phase 4 An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment Completed
Phase 4 Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel Completed
Phase 4 Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris Completed
Phase 4 A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products Completed
Phase 4 A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne Completed

Showing the 50 most-cited and recently-updated of 171 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.